CorrespondencePhentermine plus topiramate in the treatment of obesity
References (5)
- et al.
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Lancet
(2011) Mediator scandal rocks French medical community
Lancet
(2011)
There are more references available in the full text version of this article.
Cited by (8)
Progress in researches for antiobesity drugs
2016, Chinese Journal of New DrugsNew pharmacological treatments for the management of obesity
2014, Current Gastroenterology ReportsPhentermine and topiramate for the management of obesity: A review
2013, Drug Design, Development and TherapyMultifaceted individualities in pharmacological treatments of obesity
2013, Current Clinical Pharmacology
Copyright © 2011 Elsevier Ltd. All rights reserved.